Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions

Major Depressive Disorder

Interventions

DRUG

Desvenlafaxine Succinate Sustained Release

50 mg DVS SR tablet days 1-6, period 2 only.

DRUG

Midazolam

4 mg midazolam (2 mL midazolam syrup) day 1, period 1 and day 6, period 2.

Trial Locations (1)

Pfizer Investigational Site, New Haven